In the low-level p53 expression group, survival was remarkably worse in patients with positive EGFR astrocytomas compared with survival in patients with negative EGFR expression (log-rank test: p < 0.001) (Figure 4A). The gene discussed is TP53; the disease is astrocytoma (excluding glioblastoma).